In our study, older patients and those with lower baseline eGFR, lower CD4 count, lower body weight and concomitant protease inhibitor use were at increased risk of kidney toxicity, which concurs with previous studies [4,5,9,14–18]. Here, CD4 is linked to nephrotoxicity.